Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | APLNR | P35414 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7178038 | 0.81 | APLNR (0.36) | APLNRSMN1; SMN2 | |
| SCHEMBL416167 | 0.81 | APLNR (0.58) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL20711669 | 0.79 | GAA (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL28144858 | 0.79 | APLNR (0.34) | APLNRSMN1; SMN2 | |
| SCHEMBL3741329 | 0.79 | GAA (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL13760995 | 0.77 | GAA (0.36) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL5429867 | 0.77 | GAA (0.36) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL10587318 | 0.76 | APLNR (0.32) | APLNR | |
| SCHEMBL12846334 | 0.76 | GAA (0.39) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL13979304 | 0.76 | APLNR (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1035103-B1 | Process for preparing acrylic acid | ROHM & HAAS (US) | 2003-10-15 | — | — | EP | claimed |
| US-6500982-B1 | DEHYDRATION IN PRESENCE OF POLYMERIZATION INHIBITOR WITH TURNDOWN CONTROL, I.E. ADJUSTING WATER OR ORGANIC SOLVENT FED TO MAINTAIN OPTIMAL DISTILLATION COLUMN PERFORMANCE | ROHM AND HAAS COMPANY | 2002-12-31 | — | — | US | claimed |
| EP-1065197-B1 | Process for preparing (meth)acrylic acid | ROHM & HAAS (US) | 2002-11-06 | — | — | EP | claimed |
| US-6399817-B1 | CATALYTIC OXIDATION OF HYDROCARBON | ROHM AND HAAS COMPANY | 2002-06-04 | — | — | US | claimed |
| EP-1065197-A1 | Process for preparing (meth)acrylic acid | ROHM AND HAAS COMPANY (US) | 2001-01-03 | — | — | EP | claimed |
| EP-1035103-A2 | Process for preparing acrylic acid | ROHM AND HAAS COMPANY (US) | 2000-09-13 | — | — | EP | claimed |
| CN-107810204-B | Composition for immediate termination of free radical polymerization | 巴斯夫欧洲公司 | 2020-04-14 | — | — | CN | disclosed |
| US-10478513-B2 | Nitroxide containing amyloid binding agents for imaging and therapeutic uses | THE REGENTS OF THE UNIVERSITY OF CALIFONIA (US) | 2019-11-19 | — | — | US | disclosed |
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180221514-A1 | NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-08-09 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| EP-3310819-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2018-04-25 | — | — | EP | disclosed |
| US-6518452-B1 | A method of stabilizing an ester of (meth)acrylic acid against free-radical polymerization, comprising: adding to said ester of (meth)acrylic acid a polymerization inhibitor which comprises at least one nitroxyl radical and/or at least | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-11 | — | — | US | disclosed |
| EP-1177218-B1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AG (DE) | 2002-12-11 | — | — | EP | disclosed |
| EP-1177218-A1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-06 | — | — | EP | disclosed |
| US-H1957-H1 | ADDING A PHENOTHIAZINE-CONTAINING SOLUTION WHOSE SOLVENT COMPRISES AT LEAST 50% OF ITS WEIGHT OF AN N-ALKYLPYRROLIDONE | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-03 | — | — | US | disclosed |
| EP-1056711-A1 | PROCESS FOR STABILISING (METHA)ACRYLIC ESTERS AGAINST UNWANTED RADICAL POLYMERISATION | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000064947-A1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-02 | — | — | WO | disclosed |
| WO-1999007664-A1 | PROCESS FOR STABILISING (METHA)ACRYLIC ACID ESTERS AGAINST UNWANTED RADICAL POLYMERISATION | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885L3MBTL1 3957/4885KDM4E 2885/4885 |
| US-10478513-B2 | Nitroxide containing amyloid binding agents for imaging and therapeutic uses | APP, APBA1, CRYAB | GAA 1175/4885L3MBTL1 3274/4885KDM4E 3459/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | GAA 4489/4885L3MBTL1 3957/4885KDM4E 2885/4885 |
| US-20180221514-A1 | NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES | APP, APBA1, CRYAB | GAA 1049/4885L3MBTL1 3427/4885KDM4E 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.